We are thrilled to announce that Viewics has raised $10.5 million in additional financing led by existing investor Canvas Ventures and new investor Roche Venture Fund, whose portfolio includes 23andMe, Flatiron, and Lumos Pharma. City National Bank also contributed. The funds will be used to further expand our analytics platform and management solutions, as exemplified by the recent launch of our management solution for chronic kidney disease.
“Hospitals, health systems, and accountable care organizations are under intense pressure to improve patient outcomes while reducing costs,” said Dhiren Bhatia, co-founder and CEO of Viewics. “The value-based market is changing how these organizations track, measure, and report performance. Our customers recognize this shift, and are using Viewics’ solutions to achieve these goals across their organizations and patient populations.”